Quarter Period Consolidated Statement Of Income

Carna Biosciences, Inc. - Filing #7718384

Concept 2018-01-01 to
2018-09-30
2018-01-01 to
2018-09-30
2018-01-01 to
2018-09-30
2017-01-01 to
2017-09-30
2017-01-01 to
2017-09-30
2017-01-01 to
2017-09-30
Quarter period consolidated statement of income
Statement of income
Net sales
586,862,000 JPY
50,000,000 JPY
536,862,000 JPY
483,301,000 JPY
483,301,000 JPY
JPY
Cost of sales
178,918,000 JPY
167,802,000 JPY
Gross profit (loss)
407,943,000 JPY
315,498,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
1,170,699,000 JPY
792,907,000 JPY
Operating profit (loss)
-762,755,000 JPY
-876,825,000 JPY
114,069,000 JPY
-477,409,000 JPY
99,334,000 JPY
-576,743,000 JPY
Non-operating income
Interest income
15,000 JPY
37,000 JPY
Dividend income
274,000 JPY
267,000 JPY
Non-operating income
799,000 JPY
6,221,000 JPY
Non-operating expenses
Interest expenses
8,245,000 JPY
5,100,000 JPY
Non-operating expenses
11,179,000 JPY
14,957,000 JPY
Ordinary profit (loss)
-773,135,000 JPY
-486,145,000 JPY
Extraordinary losses
Impairment losses
46,946,000 JPY
19,267,000 JPY
Extraordinary losses
46,946,000 JPY
19,267,000 JPY
Profit (loss) before income taxes
-820,081,000 JPY
-505,412,000 JPY
Income taxes - current
2,971,000 JPY
3,048,000 JPY
Income taxes - deferred
-125,000 JPY
-136,000 JPY
Income taxes
2,845,000 JPY
2,912,000 JPY
Profit (loss)
-822,927,000 JPY
-508,324,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
-822,927,000 JPY
-508,324,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-632,000 JPY
18,000 JPY
Foreign currency translation adjustment
499,000 JPY
-1,238,000 JPY
Other comprehensive income
-132,000 JPY
-1,220,000 JPY
Comprehensive income
-823,060,000 JPY
-509,545,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-823,060,000 JPY
-509,545,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.